NICE LTD - SPON ADR
NICENASDAQ🏆 #1140 by market capEarnings Nov 11 · PreUS Equity
$106.81▼ $2.23 (−2.09%)
🌙 After hours$106.81▲ 0.00%Regular close · extended-hours price shownTrack NICE
Get earnings, price moves & breaking news on Telegram
24h▼ 2.1%
7d▼ 9.4%
14d▲ 1.4%
30d▼ 2.2%
ytd▼ 5.5%
1y▼ 26.2%
🏦Market Cap
$6.26B
Small Cap
📈Revenue Growth (YoY)
+7.7%
Slowing
📊Gross Margin
65.1%
High
💵FCF Margin
20.3%
Strong
⚖️P/S Ratio
2.1x
Cheap
Otter Score
84
Good
NICE LTD - SPON ADR
NICEAnalyst Ratings
Price
$106.81
Total
23
Raised
0
Lowered
5
Avg PT
$117.75
H / L
$145 / $100
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-09-24 | $145.00 | +35.80% |
Rosenblatt | Reiterated | Buy | 2026-08-06 | — | — |
DA Davidson | Reiterated | Buy | 2026-08-06 | $115.00 | +7.70% |
Morgan Stanley | Downgraded | Overweight → Equal Weight | 2026-07-21 | $111.00 | +3.90% |
Wedbush | Reiterated | Neutral | 2026-06-10 | $100.00 | −6.40% |
Cantor Fitzgerald | Reiterated | Neutral | 2026-06-10 | — | — |
Citigroup | Reiterated | Neutral | 2026-05-08 | $260.00 | +143.40% |
Citizens | Reiterated | Market Outperform | 2026-05-07 | — | — |
Barclays | Reiterated | Overweight | 2025-11-19 | $165.00 | +54.50% |
Mizuho | Reiterated | Outperform | 2025-11-18 | — | — |
Jefferies | Reiterated | Hold | 2025-11-18 | $152.00 | +42.30% |
JMP Securities | Reiterated | Market Outperform | 2025-08-26 | $200.00 | +87.20% |
Piper Sandler | Reiterated | Neutral | 2025-06-13 | $124.00 | +16.10% |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-21 | — | — |
Northland Capital Markets | Reiterated | Outperform | 2024-11-15 | — | — |
B of A Securities | Reiterated | Buy | 2024-05-17 | — | — |
Oppenheimer | Reiterated | Outperform | 2024-02-23 | $225.00 | +110.70% |
JP Morgan | Reiterated | Overweight | 2022-08-19 | — | — |
Chardan Capital | Downgraded | Buy → Neutral | 2017-11-06 | — | — |
Goldman Sachs | Reiterated | Neutral | 2017-02-10 | — | — |
Imperial Capital | Downgraded | Outperform → In Line | 2017-01-13 | — | — |
UBS | Downgraded | Buy → Neutral | 2016-05-27 | — | — |
Israel Brokerage & Investments | Downgraded | Buy → Neutral | 2012-02-21 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-09-24
$145.00
+35.80%
Rosenblatt
Reiterated · Buy · 2026-08-06
—
—
DA Davidson
Reiterated · Buy · 2026-08-06
$115.00
+7.70%
Morgan Stanley
Downgraded · Overweight → Equal Weight · 2026-07-21
$111.00
+3.90%
Wedbush
Reiterated · Neutral · 2026-06-10
$100.00
−6.40%
Cantor Fitzgerald
Reiterated · Neutral · 2026-06-10
—
—
Citigroup
Reiterated · Neutral · 2026-05-08
$260.00
+143.40%
Citizens
Reiterated · Market Outperform · 2026-05-07
—
—
Barclays
Reiterated · Overweight · 2025-11-19
$165.00
+54.50%
Mizuho
Reiterated · Outperform · 2025-11-18
—
—
Jefferies
Reiterated · Hold · 2025-11-18
$152.00
+42.30%
JMP Securities
Reiterated · Market Outperform · 2025-08-26
$200.00
+87.20%
Piper Sandler
Reiterated · Neutral · 2025-06-13
$124.00
+16.10%
Citizens Capital Markets
Reiterated · Market Outperform · 2025-02-21
—
—
Northland Capital Markets
Reiterated · Outperform · 2024-11-15
—
—
B of A Securities
Reiterated · Buy · 2024-05-17
—
—
Oppenheimer
Reiterated · Outperform · 2024-02-23
$225.00
+110.70%
JP Morgan
Reiterated · Overweight · 2022-08-19
—
—
Chardan Capital
Downgraded · Buy → Neutral · 2017-11-06
—
—
Goldman Sachs
Reiterated · Neutral · 2017-02-10
—
—
Imperial Capital
Downgraded · Outperform → In Line · 2017-01-13
—
—
UBS
Downgraded · Buy → Neutral · 2016-05-27
—
—
Israel Brokerage & Investments
Downgraded · Buy → Neutral · 2012-02-21
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space